Voya Investment Management LLC Tyme Technologies, Inc. Transaction History

Voya Investment Management LLC

$85.7 Billion
Q2 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$1.14 - $1.87 $39,266 - $64,410	-34,444 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.34 - $3.53 $2,338 - $6,159	-1,745 Reduced 4.82%	34,444 $61,000
Q4 2020 Feb 16, 2021	BUY	$0.87 - $1.26 $9,041 - $13,093	10,392 Added 40.28%	36,189 $44,000
Q2 2020 Aug 14, 2020	SELL	$0.97 - $1.7 $12,848 - $22,518	-13,246 Reduced 33.93%	25,797 $34,000
Q4 2019 Feb 14, 2020	BUY	$1.0 - $1.49 $15,113 - $22,518	15,113 Added 63.16%	39,043 $55,000
Q3 2019 Nov 14, 2019	SELL	$0.97 - $1.77 $19,517 - $35,614	-20,121 Reduced 45.68%	23,930 $28,000
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.21 $49,588 - $103,864	24,671 Added 127.3%	44,051 $163,000
Q2 2018 Aug 14, 2018	BUY	$2.05 - $4.09 $39,729 - $79,264	19,380 New	19,380 $61,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.